Name: Oncology Information System Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: MD3386
Price: 4350 USD
Availability: InStock

Oncology Information System Market Size Share Growth Opportunities and Forecast 2022

Oncology Information System Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Global Oncology Information System Market is segmented By Product and Services (Software, Professional Services, Others), By Application&nbsp;(Radiation Oncology, Medical Oncology, Surgical Oncology, Others), By End-User (Hospitals, Cancer research centers, Clinics, Others), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global Oncology Information System Market is expected to grow at a high&nbsp;CAGR during the forecasting period (2022-2029).
</blockquote>

Cancer is one of the most highly personal, complex diseases in our world today. While the various types of cancer are well-established, no two cases are ever the same. Because of this, a multidisciplinary approach is often required, with a healthcare team assembled from across the hospital. Oncology information system (OIS) is a comprehensive information and image management solution, which facilitates management and optimization of the profiles and treatment of cancer patients. It manages treatment plans, patient treatment schedules, treatment delivery, treatment summaries, and inevitable results. The OIS also acts as an information exchanger between the healthcare enterprise and radiation therapy departments. It helps ensure a healthy treatment by providing complete information about the radiation therapy and treatment results as and when needed for evaluating and improving the quality of treatment.

<h2>Market Dynamics</h2>

The global Oncology Information System market growth is driven by the growing incidence of cancer cases, the Rise of advantages provided by oncology information systems over traditional methods and growth in technological advancements, Effective government initiatives are among the key factors driving the market growth.&nbsp;

Implementing Government Initiatives is expected to drive the global Oncology Information System market growth&nbsp; in the forecast period&nbsp;

Governments from all over the world are planning reforms and introducing new regulations that would help in the enterprise-wide and nationwide adoption of information technologies, including oncology information systems, which aid in the transformation of healthcare systems. For example, in the US, the Health Information Technology for Economic and Clinical Health (HITECH) Act&mdash;enacted under the American Recovery and Reinvestment Act (ARRA)&mdash;allocated funding for incentivizing hospitals and physicians who demonstrate meaningful use of EHRs. The availability of advanced Healthcare IT solutions for cancer care is generating significant interest among end-users owing to the better treatment outcomes promised by them.

Listed below are initiatives in recent years:

<ul>
	<li>The NHS launched the Five Year Forward View in the UK to make all patient records &ldquo;largely paperless&rdquo; in 2020.</li>
	<li>The National Electronic Health Record (NEHR) project was launched in Singapore to enable the vision of &ldquo;One Patient, One Health Record,&rdquo; with a budget of USD 127.83 million (SGD 176 million).</li>
</ul>

&nbsp;

High cost associated with Oncology information systems is likely to hamper the market growth&nbsp;

The total cost of oncology information systems for different medical devices is considerably high. Affordability is a significant challenge for healthcare organizations, especially in emerging economies, where it is typically complicated to receive budgetary approvals for IT solutions over medical equipment. Smaller healthcare organizations struggle to implement Internet connectivity to medical devices, mainly due to difficulties in implementing multiple networks with health setups, the lack of wireless connectivity options, and a need to install security layers to avoid data breaches. The infrastructural costs for implementing an oncology information system and associating it with different devices with distinct interfaces form a major obstacle to market growth in emerging regions. The implementation and subscription/licensing fees for integration solutions are a major financial burden and add to the budgetary woes faced by many hospitals.

<h2>COVID-19 Impact Analysis</h2>

As a result of the pandemic, during March 2020 and throughout the second quarter of 2020, access to customers to sell and implement the oncology information systems diminished as hospitals became primarily focused on the COVID-19 pandemic. The pandemic has led to a significant decrease in the demand for oncology information solutions. The pandemic has also affected the oncology field since doctors cannot concentrate on regular patients since they are being redeployed for treating COVID-19 patients. Therefore, performing oncology surgery and therapy has become a significant challenge with the non-availability of hospital staff and operation facilities. Furthermore, the market for oncology information systems is expecting to recover the losses by the fourth quarter of 2020.

<h2>Segment Analysis</h2>

Based on Product &amp; Services, the global oncology information system market is segmented into Software, Professional Services, Others.

The software segment accounted for the fastest market growth over the forecast period due to the increasing prevalence of cancers. For instance, as per the Globocan 2020 fact sheet estimates, about 19,292,789 new cancer cases were diagnosed worldwide. Additionally, according to International Agency for Research on Cancer (IARC) estimates, by 2040, global cancer cases are expected to grow to 27.5 million new cancer cases worldwide and the advantages offered by software, such as streamlining fine-tuning the patient management and data management processes. It also performs critical functions, such as comprehensive patient management, treatment planning, monitoring activities, clinical regimes, and medication information. A timely upgrade of software is essential for synchronizing software with the latest analytics, and the OIS software can help the hospitals and oncology centres manage the treatment effectively and efficiently. In this, the treatment planning system is expected to expand at the highest CAGR owing to the benefits offered by these systems, such as proper treatment planning and scheduling. These are the heart of radiation therapy and an essential factor for improving patient outcomes. Once the image datasets are loaded, and tumors identified, these systems develop a detailed treatment plan. It also calculates the expected dose distribution, including the variables, such as tissue energy level penetration affected by the type of tissue the beamlines encounter. For instance, OncoEMR is a cloud-based electronic medical record software developed by Flatiron designed to address the intricacy of dosage management requirements and to offer help to oncology practices. This platform offers an array of capabilities such as integrated ePrescribing, PQRI reporting, practice management, and other crucial oncology functionalities, including but not limited to document search, regimen management, visit notes, and clinical benchmarking.

The professional services segment is divided into implementation services, consulting/optimization services and post-sale and maintenance services. Oncology information systems company has also adopted consignment model, according to which company places the treatment planning systems and treatment delivery systems its customers and sales are made according to the implementation of medical devices. Such initiatives undertaken by significant product manufacturers are expected to increase their brand awareness among target end-users and sensitize them about their role in preventive cancer care.

Based on the Application, the global oncology information system market is segmented into Radiation Oncology, Medical Oncology, Surgical Oncology and Others

The radiation oncology segment accounted for the most significant share of the market. The increasing installation base for radiotherapy devices, a growing number of radiosurgery procedures related to fractures, rapid cancer growth affected population across the globe, and the development of advanced radiology information systems and radiation treatment planning systems. For instance, as per the Royal Australian and New Zealand College of Radiologists, more than 100,000 Australians are diagnosed with cancer every year are factors expected to drive the growth of this market segment in the coming years. For instance, Elekta Care Management software helps you efficiently manage all aspects of the Radiation oncology program with MOSAIQ Radiation Oncology. All patient information is collected and accessible, from diagnosis through treatment and follow-up, to deliver the best possible care for every patient.

The medical oncology segment is increasing rapidly due to the increasing usage of immunotherapy, chemotherapy, and hormonal therapy. For instance, In August 2018, the United States Food and Drug Administration approved a combination of immunotherapeutic drugs ipilimumab (Yervoy), and nivolumab (Opdivo) to treat metastatic colorectal cancer.

Surgical Oncology has less growth due to high cost and time consumables and also advancements in technology made them less attractive.

Based on End-User, the global Oncology information systems market is segmented into Hospitals, Cancer Research centers, clinics, others.

Due to the growing patient population, the hospital&#39;s segment held the largest market share. This is mainly owing to the increasing number of patients suffering from conditions that are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment. Also, most of the cancer medications can only be administrated intravenously under the supervision of medical practioners at these locations.

<h2>Geographical Analysis</h2>

North America holds the largest market in the global cancer stem cells market due to the high incidence of cancer, according to the International Agency for Research on Cancer (IARC), which claims 13 million new cancer cases worldwide. The World Cancer Report provides that the incidence rate of new cancer cases is increased by 50% to 15 million in 2020. The existence of a highly developed healthcare system, the high degree of acceptance by medical practitioners of novel chemotherapy and immunotherapy methods, the total availability of advanced technological tools, FDA approval of new drugs and also the presence of a vast number of organizations engaged in R&amp;D activities. For instance, By Elekta-&nbsp;The recent release of Mosaiq, version 15, sports several features meant to enhance collaborative workflow between cancer care team members. IQscripts allows users to generate customized workflows, with each step auto-triggered upon completion of the preceding step. The image review feature reduces image load times when viewing cone-beam computed tomography (CBCT) for treatment planning to streamline workflow.&nbsp;

The Asia Pacific is expected to be the fastest-growing market over the forecast period owing to the increasing prevalence rate, increasing focus on preventive care, and government initiatives promoting technological innovations.&nbsp;

<h2>Competitive Landscape&nbsp;</h2>

The Global Oncology Information Systems Market is moderately competitive with some key competitors like Cerner (PowerChart Oncology); Elekta (Mosaiq); Flatiron (OncoEMR); McKesson Specialty Health (iKnowMed); Varian Medical Systems, Inc (Aria), Koninklijke Philips N.V, Siemens Healthineers, Epic Systems Corporation, Bogardus Medical Systems, Inc, GE Healthcare, RaySearch Laboratories AB. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the market&rsquo;s growth globally. For instance, RaySearch Laboratories AB announced on April 16, 2021, that the new carbon ion therapy (radiation therapy) centre at Yamagata University Hospital in Northern Japan has treated its first patients using the RayStation&reg;* treatment planning system in combination with Toshiba&rsquo;s treatment delivery system. The centre opened this year, and the first treatments were carried out in February 2021.

RaySearch Laboratories&nbsp;

Overview: RaySearch Laboratories&nbsp;is a Swedish medical technology company that develops software used in the Radiation therapy of cancer. The company markets its products and services worldwide and has subsidiaries in the US, Singapore, Belgium, France, Germany and the UK. The RaySearch story begins in 2000 when founder and CEO, Johan Lof, decides to start the company based on the scientific knowledge acquired during his PhD on radiation treatment of moving tumors at the Karolinska Institute. RaySearch concludes its first partnership agreement with Philips, the leading treatment planning system vendor at the time.&nbsp;

Product Portfolio: RayStation is a treatment planning system for radiation therapy of cancer.&nbsp;

Key developments:

In 2020, RayCare 4A and 4B arrived with new functionalities and enhancements. Elsewhere, RaySearch entered into an interoperability agreement with Varian Medical Systems and launched the oncology analytics system RayIntelligence.

Why Purchase the Report?

<ul>
	<li>Visualize the composition of the Global Oncology Information Systems Market segmentation by procedure, disorder, end-user and region.</li>
	<li>Identify commercial opportunities in Global Oncology Information Systems Market by analyzing trends and co-development deals.&nbsp;</li>
	<li>Excel data sheet with thousands of data points of Global Oncology Information Systems Market-level 4/5 segmentation.</li>
	<li>PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.&nbsp;</li>
	<li>Disorder mapping in excel for the key Disorder of all major market players</li>
</ul>

The Global Oncology Information Systems Market report would provide access to an approx. 61 market data table, 54 figures and 180 pages.&nbsp;

Target Audience

<ul>
	<li>Service Providers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Education &amp; Research Institutes</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
	<li>Manufacturers</li>
</ul>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/oncology-therapy-market">Oncology Therapy Market</a>

<a href="https://www.datamintelligence.com/research-report/oncology-nutrition-market">Oncology Nutrition Market</a>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Market Snippet by Product &amp; Services</li>
		<li>Market Snippet by Application&nbsp;</li>
		<li>Market Snippet by End-users</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Implementing Government Initiatives</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>High cost associated with Oncology information systems</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product &amp; Services</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product &amp; services</li>
		<li>Market Attractiveness Index, By Product &amp; Services
		<ol>
			<li>Software*</li>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>

		<ol>
			<li>Professional Services</li>
			<li>Others</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application&nbsp;</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
		<li>Market Attractiveness Index, By Application&nbsp;
		<ol>
			<li>Radiation Oncology*
			<ol>
				<li>Introduction</li>
				<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
			</ol>
			</li>
			<li>Medical Oncology</li>
			<li>Surgical Oncology</li>
			<li>Others</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Global CD-Antigen Cancer Therapy Market &ndash; By End-User</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
		<li>Market Attractiveness Index, By End-User
		<ol>
			<li>Hospitals*
			<ol>
				<li>Introduction</li>
				<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
			</ol>
			</li>
			<li>Cancer research centers</li>
			<li>Clinics</li>
			<li>Others&nbsp;&nbsp;</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction&nbsp;</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region</li>
		<li>Market Attractiveness Index, By Region</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product &amp; services</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product &amp; Services</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product &amp; Services</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product &amp; Services</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product &amp; Services</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>RaySearch Laboratories*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Cerner (PowerChart Oncology);&nbsp;</li>
		<li>Elekta (Mosaiq);&nbsp;</li>
		<li>Flatiron (OncoEMR);&nbsp;</li>
		<li>McKesson Specialty Health (iKnowMed);&nbsp;</li>
		<li>Varian Medical Systems, Inc (Aria),&nbsp;</li>
		<li>Koninklijke Philips N.V,&nbsp;</li>
		<li>Siemens Healthineers,&nbsp;</li>
		<li>Epic Systems Corporation,&nbsp;</li>
		<li>Bogardus Medical Systems, Inc.(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Premium Insights</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">DataM Intelligence&nbsp;</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 1 Global Oncology Information Systems Market Value, By Product &amp; Services, 2021,2025 &amp; 2029 ($ Million)

Table 2 Global Oncology Information Systems Market Value, By Application, 2021,2025 &amp; 2029 ($ Million)

Table 3 Global Oncology Information Systems Market Value, By End-Users, 2021,2025 &amp; 2029 ($ Million)

Table 4 Global Oncology Information Systems Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 5 Global Oncology Information Systems Market Value, By Product &amp; Services, 2021,2025 &amp; 2029 ($ Million)

Table 6 Global Oncology Information Systems Market Value, By Product &amp; Services, 2018-2029 ($ Million)

Table 7 Global Oncology Information Systems Market Value, By Application, 2021,2025 &amp; 2029 ($ Million)

Table 8 Global Oncology Information Systems Market Value, By Application, 2018-2029 ($ Million)

Table 9 Global Oncology Information Systems Market Value, By End-Users, 2021,2025 &amp; 2029 ($ Million)

Table 10 Global Oncology Information Systems Market Value, By End-Users, 2018-2029 ($ Million)

Table 11 Global Oncology Information Systems Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 12 Global Oncology Information Systems Market Value, By Region, 2018-2029 ($ Million)

Table 13 North America Oncology Information Systems Market Value, By Product &amp; Services, 2018-2029 ($ Million)

Table 14 North America Oncology Information Systems Market Value, By Application, 2018-2029 ($ Million)

Table 15 North America Oncology Information Systems Market Value, By End-Users, 2018-2029 ($ Million)

Table 16 North America Oncology Information Systems Market Value, By Country, 2018-2029 ($ Million)

Table 17 South America Oncology Information Systems Market Value, By Product &amp; Services, 2018-2029 ($ Million)

Table 18 South America Oncology Information Systems Market Value, By Application, 2018-2029 ($ Million)

Table 19 South America Oncology Information Systems Market Value, By End-Users, 2018-2029 ($ Million)

Table 20 South America Oncology Information Systems Market Value, By Country, 2018-2029 ($ Million)

Table 21 Europe Oncology Information Systems Market Value, By Product &amp; Services, 2018-2029 ($ Million)

Table 22 Europe Oncology Information Systems Market Value, By Application, 2018-2029 ($ Million)

Table 23 Europe Oncology Information Systems Market Value, By End-Users, 2018-2029 ($ Million)

Table 24 Europe Oncology Information Systems Market Value, By Country, 2018-2029 ($ Million)

Table 25 Asia-Pacific Oncology Information Systems Market Value, By Product &amp; Services, 2018-2029 ($ Million)

Table 26 Asia-Pacific Oncology Information Systems Market Value, By Application, 2018-2029 ($ Million)

Table 27 Asia-Pacific Oncology Information Systems Market Value, By End-Users, 2018-2029 ($ Million)

Table 28 Asia-Pacific Oncology Information Systems Market Value, By Country, 2018-2029 ($ Million)

Table 29 Middle East &amp; Africa Oncology Information Systems Market Value, By Product &amp; Services, 2018-2029 ($ Million)

Table 30 Middle East &amp; Africa Oncology Information Systems Market Value, By Application, 2018-2029 ($ Million)

Table 31 Middle East &amp; Africa Oncology Information Systems Market Value, By End-Users, 2018-2029 ($ Million)

Table 32 RaySearch Laboratories: Overview

Table 33 RaySearch Laboratories: Product Portfolio

Table 34 RaySearch Laboratories: Key Developments

Table 35 Varian Medical Systems, Inc: Overview

Table 36 Varian Medical Systems, Inc: Product Portfolio

Table 37 Varian Medical Systems, Inc: Key Developments

Table 38 Elekta: Overview

Table 39 Elekta: Product Portfolio

Table 40 Elekta: Key Developments

Table 41 Flatiron: Overview

Table 42 Flatiron: Product Portfolio

Table 43 Flatiron: Key Developments

Table 44 McKesson Specialty Health: Overview

Table 45 McKesson Specialty Health: Product Portfolio

Table 46 McKesson Specialty Health: Key Developments

Table 47 Koninklijke Philips N.V: Overview

Table 48 Koninklijke Philips N.V: Product Portfolio

Table 49 Koninklijke Philips N.V: Key Developments

Table 50 Siemens Healthineers: Overview

Table 51 Siemens Healthineers: Product Portfolio

Table 52 Siemens Healthineers: Key Developments

Table 53 Epic Systems Corporation: Overview

Table 54 Epic Systems Corporation: Product Portfolio

Table 55 Epic Systems Corporation: Key Developments

Table 56 Bogardus Medical Systems, Inc: Overview

Table 57 Bogardus Medical Systems, Inc: Product Portfolio

Table 58 Bogardus Medical Systems, Inc: Key Developments

Table 59 Cerner: Overview

Table 60 Cerner: Product Portfolio

Table 61 Cerner: Key Developments

&nbsp;

List of Figures

&nbsp;

Figure 1 Global Oncology Information Systems Market Share, By Product &amp; Services, 2021 &amp; 2029 (%)

Figure 2 Global Oncology Information Systems Market Share, By Application, 2021 &amp; 2029 (%)

Figure 3 Global Oncology Information Systems Market Share, By End-Users, 2021 &amp; 2029 (%)

Figure 4 Global Oncology Information Systems Market Share, By Region, 2021 &amp; 2029 (%)

Figure 5 Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 6 Global Oncology Information Systems Market Y-o-Y Growth, By Product &amp; Services, 2021-2029 (%)

Figure 7 Software: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 8 Professional Services: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 9 Others: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 10 Global Oncology Information Systems Market Y-o-Y Growth, By Application, 2021-2029 (%)

Figure 11 Radiation Oncology: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 12 Medical Oncology: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 13 Surgical Oncology: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 14 Others: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 15 Global Oncology Information Systems Market Y-o-Y Growth, By End-Users, 2021-2029 (%)

Figure 16 Hospitals: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 17 Clinics: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 18 Cancer Research Institutes: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 19 Others: Global Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 20 Global Oncology Information Systems Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 21 North America Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 22 North America Oncology Information Systems Market Share, By Product &amp; Services, 2021 &amp; 2029 (%)

Figure 23 North America Oncology Information Systems Market Share, By Application, 2021 &amp; 2029 (%)

Figure 24 North America Oncology Information Systems Market Share, By End-Users, 2021 &amp; 2029 (%)

Figure 25 North America Oncology Information Systems Market Share, By Country, 2021 &amp; 2029 (%)

Figure 26 South America Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 27 South America Oncology Information Systems Market Share, By Product &amp; Services, 2021 &amp; 2029 (%)

Figure 28 South America Oncology Information Systems Market Share, By Application, 2021 &amp; 2029 (%)

Figure 29 South America Oncology Information Systems Market Share, By End-Users, 2021 &amp; 2029 (%)

Figure 30 South America Oncology Information Systems Market Share, By Country, 2021 &amp; 2029 (%)

Figure 31 Europe Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 32 Europe Oncology Information Systems Market Share, By Product &amp; Services, 2021 &amp; 2029 (%)

Figure 33 Europe Oncology Information Systems Market Share, By Application, 2021 &amp; 2029 (%)

Figure 34 Europe Oncology Information Systems Market Share, By End-Users, 2021 &amp; 2029 (%)

Figure 35 Europe Oncology Information Systems Market Share, By Country, 2021 &amp; 2029 (%)

Figure 36 Asia-Pacific Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 37 Asia-Pacific Oncology Information Systems Market Share, By Product &amp; Services, 2021 &amp; 2029 (%)

Figure 38 Asia-Pacific Oncology Information Systems Market Share, By Application, 2021 &amp; 2029 (%)

Figure 39 Asia-Pacific Oncology Information Systems Market Share, By End-Users, 2021 &amp; 2029 (%)

Figure 40 Asia-Pacific Oncology Information Systems Market Share, By Country, 2021 &amp; 2029 (%)

Figure 41 Middle East &amp; Africa Oncology Information Systems Market Value, 2018-2029 ($ Million)

Figure 42 Middle East &amp; Africa Oncology Information Systems Market Share, By Product &amp; Services, 2021 &amp; 2029 (%)

Figure 43 Middle East &amp; Africa Oncology Information Systems Market Share, By Application, 2021 &amp; 2029 (%)

Figure 44 Middle East &amp; Africa Oncology Information Systems Market Share, By End-Users, 2021 &amp; 2029 (%)

Figure 45 RaySearch Laboratories: Financials

Figure 46 Varian Medical Systems, Inc: Financials

Figure 47 Elekta: Financials

Figure 48 Flatiron: Financials

Figure 49 McKesson Specialty Health: Financials

Figure 50 Koninklijke Philips N.V: Financials

Figure 51 Siemens Healthineers: Financials

Figure 52 Epic Systems Corporation: Financials

Figure 53 Bogardus Medical Systems, Inc: Financials

Figure 54 Cerner: Financials